Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 169 to 177 of 177 entries
Sorted by: Best Match Show Resources per page
Global Chronic Total Occlusion Crossing Algorithm: JACC State-of-the-Art Review.

Journal of the American College of Cardiology

Wu EB, Brilakis ES, Mashayekhi K, Tsuchikane E, Alaswad K, Araya M, Avran A, Azzalini L, Babunashvili AM, Bayani B, Behnes M, Bhindi R, Boudou N, Boukhris M, Bozinovic NZ, Bryniarski L, Bufe A, Buller CE, Burke MN, Buttner A, Cardoso P, Carlino M, Chen JY, Christiansen EH, Colombo A, Croce K, de Los Santos FD, de Martini T, Dens J, di Mario C, Dou K, Egred M, Elbarouni B, ElGuindy AM, Escaned J, Furkalo S, Gagnor A, Galassi AR, Garbo R, Gasparini G, Ge J, Ge L, Goel PK, Goktekin O, Gonzalo N, Grancini L, Hall A, Hanna Quesada FL, Hanratty C, Harb S, Harding SA, Hatem R, Henriques JPS, Hildick-Smith D, Hill JM, Hoye A, Jaber W, Jaffer FA, Jang Y, Jussila R, Kalnins A, Kalyanasundaram A, Kandzari DE, Kao HL, Karmpaliotis D, Kassem HH, Khatri J, Knaapen P, Kornowski R, Krestyaninov O, Kumar AVG, Lamelas PM, Lee SW, Lefevre T, Leung R, Li Y, Li Y, Lim ST, Lo S, Lombardi W, Maran A, McEntegart M, Moses J, Munawar M, Navarro A, Ngo HM, Nicholson W, Oksnes A, Olivecrona GK, Padilla L, Patel M, Pershad A, Postu M, Qian J, Quadros A, Rafeh NA, Råmunddal T, Prakasa Rao VS, Reifart N, Riley RF, Rinfret S, Saghatelyan M, Sianos G, Smith E, Spaedy A, Spratt J, Stone G, Strange JW, Tammam KO, Thompson CA, Toma A, Tremmel JA, Trinidad RS, Ungi I, Vo M, Vu VH, Walsh S, Werner G, Wojcik J, Wollmuth J, Xu B, Yamane M, Ybarra LF, Yeh RW, Zhang Q.
PMID: 34412818
J Am Coll Cardiol. 2021 Aug 24;78(8):840-853. doi: 10.1016/j.jacc.2021.05.055.

The authors developed a global chronic total occlusion crossing algorithm following 10 steps: 1) dual angiography; 2) careful angiographic review focusing on proximal cap morphology, occlusion segment, distal vessel quality, and collateral circulation; 3) approaching proximal cap ambiguity using...

Cite
Wu EB, Brilakis ES, Mashayekhi K, et al. Global Chronic Total Occlusion Crossing Algorithm: JACC State-of-the-Art Review. J Am Coll Cardiol. 2021;78(8):840-853doi: 10.1016/j.jacc.2021.05.055.
Wu, E. B., Brilakis, E. S., Mashayekhi, K., Tsuchikane, E., Alaswad, K., Araya, M., Avran, A., Azzalini, L., Babunashvili, A. M., Bayani, B., Behnes, M., Bhindi, R., Boudou, N., Boukhris, M., Bozinovic, N. Z., Bryniarski, L., Bufe, A., Buller, C. E., Burke, M. N., Buttner, A., Cardoso, P., Carlino, M., Chen, J. Y., Christiansen, E. H., Colombo, A., Croce, K., de Los Santos, F. D., de Martini, T., Dens, J., di Mario, C., Dou, K., Egred, M., Elbarouni, B., ElGuindy, A. M., Escaned, J., Furkalo, S., Gagnor, A., Galassi, A. R., Garbo, R., Gasparini, G., Ge, J., Ge, L., Goel, P. K., Goktekin, O., Gonzalo, N., Grancini, L., Hall, A., Hanna Quesada, F. L., Hanratty, C., Harb, S., Harding, S. A., Hatem, R., Henriques, J. P. S., Hildick-Smith, D., Hill, J. M., Hoye, A., Jaber, W., Jaffer, F. A., Jang, Y., Jussila, R., Kalnins, A., Kalyanasundaram, A., Kandzari, D. E., Kao, H. L., Karmpaliotis, D., Kassem, H. H., Khatri, J., Knaapen, P., Kornowski, R., Krestyaninov, O., Kumar, A. V. G., Lamelas, P. M., Lee, S. W., Lefevre, T., Leung, R., Li, Y., Li, Y., Lim, S. T., Lo, S., Lombardi, W., Maran, A., McEntegart, M., Moses, J., Munawar, M., Navarro, A., Ngo, H. M., Nicholson, W., Oksnes, A., Olivecrona, G. K., Padilla, L., Patel, M., Pershad, A., Postu, M., Qian, J., Quadros, A., Rafeh, N. A., Råmunddal, T., Prakasa Rao, V. S., Reifart, N., Riley, R. F., Rinfret, S., Saghatelyan, M., Sianos, G., Smith, E., Spaedy, A., Spratt, J., Stone, G., Strange, J. W., Tammam, K. O., Thompson, C. A., Toma, A., Tremmel, J. A., Trinidad, R. S., Ungi, I., Vo, M., Vu, V. H., Walsh, S., Werner, G., Wojcik, J., Wollmuth, J., Xu, B., Yamane, M., Ybarra, L. F., Yeh, R. W., & Zhang, Q. (2021). Global Chronic Total Occlusion Crossing Algorithm: JACC State-of-the-Art Review. Journal of the American College of Cardiology, 78(8), 840-853. https://doi.org/10.1016/j.jacc.2021.05.055
Wu, Eugene B, et al. "Global Chronic Total Occlusion Crossing Algorithm: JACC State-of-the-Art Review." Journal of the American College of Cardiology vol. 78,8 (2021): 840-853. doi: https://doi.org/10.1016/j.jacc.2021.05.055
Wu EB, Brilakis ES, Mashayekhi K, Tsuchikane E, Alaswad K, Araya M, Avran A, Azzalini L, Babunashvili AM, Bayani B, Behnes M, Bhindi R, Boudou N, Boukhris M, Bozinovic NZ, Bryniarski L, Bufe A, Buller CE, Burke MN, Buttner A, Cardoso P, Carlino M, Chen JY, Christiansen EH, Colombo A, Croce K, de Los Santos FD, de Martini T, Dens J, di Mario C, Dou K, Egred M, Elbarouni B, ElGuindy AM, Escaned J, Furkalo S, Gagnor A, Galassi AR, Garbo R, Gasparini G, Ge J, Ge L, Goel PK, Goktekin O, Gonzalo N, Grancini L, Hall A, Hanna Quesada FL, Hanratty C, Harb S, Harding SA, Hatem R, Henriques JPS, Hildick-Smith D, Hill JM, Hoye A, Jaber W, Jaffer FA, Jang Y, Jussila R, Kalnins A, Kalyanasundaram A, Kandzari DE, Kao HL, Karmpaliotis D, Kassem HH, Khatri J, Knaapen P, Kornowski R, Krestyaninov O, Kumar AVG, Lamelas PM, Lee SW, Lefevre T, Leung R, Li Y, Li Y, Lim ST, Lo S, Lombardi W, Maran A, McEntegart M, Moses J, Munawar M, Navarro A, Ngo HM, Nicholson W, Oksnes A, Olivecrona GK, Padilla L, Patel M, Pershad A, Postu M, Qian J, Quadros A, Rafeh NA, Råmunddal T, Prakasa Rao VS, Reifart N, Riley RF, Rinfret S, Saghatelyan M, Sianos G, Smith E, Spaedy A, Spratt J, Stone G, Strange JW, Tammam KO, Thompson CA, Toma A, Tremmel JA, Trinidad RS, Ungi I, Vo M, Vu VH, Walsh S, Werner G, Wojcik J, Wollmuth J, Xu B, Yamane M, Ybarra LF, Yeh RW, Zhang Q. Global Chronic Total Occlusion Crossing Algorithm: JACC State-of-the-Art Review. J Am Coll Cardiol. 2021 Aug 24;78(8):840-853. doi: 10.1016/j.jacc.2021.05.055. PMID: 34412818.
Copy Download .nbib Format: NLM
Importance of In-Hospital Prospective Registry and Infectious Endocarditis Heart Team to Monitor and Improve Quality of Care in Patients with Infectious Endocarditis.

Journal of clinical medicine

Van Camp G, Beles M, Penicka M, Schelfaut D, Wouters S, De Raedt H, Wyffels E, Spapen J, Nasser R, Balogh Z, Albano M, De Beenhouwer H, Van Vaerenbergh K, Van Praet F, Degrieck I, Stockman B, Casselman F, Collet C.
PMID: 34501278
J Clin Med. 2021 Aug 26;10(17). doi: 10.3390/jcm10173832.

AIM: To investigate the value of prospective in-hospital registry data and the impact of an infectious endocarditis heart team approach (IEHT) on improvement in quality of care and monitor outcomes in hospitalized patients with IE.METHODS: Between December 2014 and...

Cite
Van Camp G, Beles M, Penicka M, et al. Importance of In-Hospital Prospective Registry and Infectious Endocarditis Heart Team to Monitor and Improve Quality of Care in Patients with Infectious Endocarditis. J Clin Med. 2021;10(17)doi: 10.3390/jcm10173832.
Van Camp, G., Beles, M., Penicka, M., Schelfaut, D., Wouters, S., De Raedt, H., Wyffels, E., Spapen, J., Nasser, R., Balogh, Z., Albano, M., De Beenhouwer, H., Van Vaerenbergh, K., Van Praet, F., Degrieck, I., Stockman, B., Casselman, F., & Collet, C. (2021). Importance of In-Hospital Prospective Registry and Infectious Endocarditis Heart Team to Monitor and Improve Quality of Care in Patients with Infectious Endocarditis. Journal of clinical medicine, 10(17), . https://doi.org/10.3390/jcm10173832
Van Camp, Guy, et al. "Importance of In-Hospital Prospective Registry and Infectious Endocarditis Heart Team to Monitor and Improve Quality of Care in Patients with Infectious Endocarditis." Journal of clinical medicine vol. 10,17 (2021). doi: https://doi.org/10.3390/jcm10173832
Van Camp G, Beles M, Penicka M, Schelfaut D, Wouters S, De Raedt H, Wyffels E, Spapen J, Nasser R, Balogh Z, Albano M, De Beenhouwer H, Van Vaerenbergh K, Van Praet F, Degrieck I, Stockman B, Casselman F, Collet C. Importance of In-Hospital Prospective Registry and Infectious Endocarditis Heart Team to Monitor and Improve Quality of Care in Patients with Infectious Endocarditis. J Clin Med. 2021 Aug 26;10(17). doi: 10.3390/jcm10173832. PMID: 34501278; PMCID: PMC8432016.
Copy Download .nbib Format: NLM
Global Chronic Total Occlusion Crossing Algorithm: JACC State-of-the-Art Review.

Journal of the American College of Cardiology

Wu EB, Brilakis ES, Mashayekhi K, Tsuchikane E, Alaswad K, Araya M, Avran A, Azzalini L, Babunashvili AM, Bayani B, Behnes M, Bhindi R, Boudou N, Boukhris M, Bozinovic NZ, Bryniarski L, Bufe A, Buller CE, Burke MN, Buttner A, Cardoso P, Carlino M, Chen JY, Christiansen EH, Colombo A, Croce K, de Los Santos FD, de Martini T, Dens J, di Mario C, Dou K, Egred M, Elbarouni B, ElGuindy AM, Escaned J, Furkalo S, Gagnor A, Galassi AR, Garbo R, Gasparini G, Ge J, Ge L, Goel PK, Goktekin O, Gonzalo N, Grancini L, Hall A, Hanna Quesada FL, Hanratty C, Harb S, Harding SA, Hatem R, Henriques JPS, Hildick-Smith D, Hill JM, Hoye A, Jaber W, Jaffer FA, Jang Y, Jussila R, Kalnins A, Kalyanasundaram A, Kandzari DE, Kao HL, Karmpaliotis D, Kassem HH, Khatri J, Knaapen P, Kornowski R, Krestyaninov O, Kumar AVG, Lamelas PM, Lee SW, Lefevre T, Leung R, Li Y, Li Y, Lim ST, Lo S, Lombardi W, Maran A, McEntegart M, Moses J, Munawar M, Navarro A, Ngo HM, Nicholson W, Oksnes A, Olivecrona GK, Padilla L, Patel M, Pershad A, Postu M, Qian J, Quadros A, Rafeh NA, Råmunddal T, Prakasa Rao VS, Reifart N, Riley RF, Rinfret S, Saghatelyan M, Sianos G, Smith E, Spaedy A, Spratt J, Stone G, Strange JW, Tammam KO, Thompson CA, Toma A, Tremmel JA, Trinidad RS, Ungi I, Vo M, Vu VH, Walsh S, Werner G, Wojcik J, Wollmuth J, Xu B, Yamane M, Ybarra LF, Yeh RW, Zhang Q.
PMID: 34412818
J Am Coll Cardiol. 2021 Aug 24;78(8):840-853. doi: 10.1016/j.jacc.2021.05.055.

The authors developed a global chronic total occlusion crossing algorithm following 10 steps: 1) dual angiography; 2) careful angiographic review focusing on proximal cap morphology, occlusion segment, distal vessel quality, and collateral circulation; 3) approaching proximal cap ambiguity using...

Cite
Wu EB, Brilakis ES, Mashayekhi K, et al. Global Chronic Total Occlusion Crossing Algorithm: JACC State-of-the-Art Review. J Am Coll Cardiol. 2021;78(8):840-853doi: 10.1016/j.jacc.2021.05.055.
Wu, E. B., Brilakis, E. S., Mashayekhi, K., Tsuchikane, E., Alaswad, K., Araya, M., Avran, A., Azzalini, L., Babunashvili, A. M., Bayani, B., Behnes, M., Bhindi, R., Boudou, N., Boukhris, M., Bozinovic, N. Z., Bryniarski, L., Bufe, A., Buller, C. E., Burke, M. N., Buttner, A., Cardoso, P., Carlino, M., Chen, J. Y., Christiansen, E. H., Colombo, A., Croce, K., de Los Santos, F. D., de Martini, T., Dens, J., di Mario, C., Dou, K., Egred, M., Elbarouni, B., ElGuindy, A. M., Escaned, J., Furkalo, S., Gagnor, A., Galassi, A. R., Garbo, R., Gasparini, G., Ge, J., Ge, L., Goel, P. K., Goktekin, O., Gonzalo, N., Grancini, L., Hall, A., Hanna Quesada, F. L., Hanratty, C., Harb, S., Harding, S. A., Hatem, R., Henriques, J. P. S., Hildick-Smith, D., Hill, J. M., Hoye, A., Jaber, W., Jaffer, F. A., Jang, Y., Jussila, R., Kalnins, A., Kalyanasundaram, A., Kandzari, D. E., Kao, H. L., Karmpaliotis, D., Kassem, H. H., Khatri, J., Knaapen, P., Kornowski, R., Krestyaninov, O., Kumar, A. V. G., Lamelas, P. M., Lee, S. W., Lefevre, T., Leung, R., Li, Y., Li, Y., Lim, S. T., Lo, S., Lombardi, W., Maran, A., McEntegart, M., Moses, J., Munawar, M., Navarro, A., Ngo, H. M., Nicholson, W., Oksnes, A., Olivecrona, G. K., Padilla, L., Patel, M., Pershad, A., Postu, M., Qian, J., Quadros, A., Rafeh, N. A., Råmunddal, T., Prakasa Rao, V. S., Reifart, N., Riley, R. F., Rinfret, S., Saghatelyan, M., Sianos, G., Smith, E., Spaedy, A., Spratt, J., Stone, G., Strange, J. W., Tammam, K. O., Thompson, C. A., Toma, A., Tremmel, J. A., Trinidad, R. S., Ungi, I., Vo, M., Vu, V. H., Walsh, S., Werner, G., Wojcik, J., Wollmuth, J., Xu, B., Yamane, M., Ybarra, L. F., Yeh, R. W., & Zhang, Q. (2021). Global Chronic Total Occlusion Crossing Algorithm: JACC State-of-the-Art Review. Journal of the American College of Cardiology, 78(8), 840-853. https://doi.org/10.1016/j.jacc.2021.05.055
Wu, Eugene B, et al. "Global Chronic Total Occlusion Crossing Algorithm: JACC State-of-the-Art Review." Journal of the American College of Cardiology vol. 78,8 (2021): 840-853. doi: https://doi.org/10.1016/j.jacc.2021.05.055
Wu EB, Brilakis ES, Mashayekhi K, Tsuchikane E, Alaswad K, Araya M, Avran A, Azzalini L, Babunashvili AM, Bayani B, Behnes M, Bhindi R, Boudou N, Boukhris M, Bozinovic NZ, Bryniarski L, Bufe A, Buller CE, Burke MN, Buttner A, Cardoso P, Carlino M, Chen JY, Christiansen EH, Colombo A, Croce K, de Los Santos FD, de Martini T, Dens J, di Mario C, Dou K, Egred M, Elbarouni B, ElGuindy AM, Escaned J, Furkalo S, Gagnor A, Galassi AR, Garbo R, Gasparini G, Ge J, Ge L, Goel PK, Goktekin O, Gonzalo N, Grancini L, Hall A, Hanna Quesada FL, Hanratty C, Harb S, Harding SA, Hatem R, Henriques JPS, Hildick-Smith D, Hill JM, Hoye A, Jaber W, Jaffer FA, Jang Y, Jussila R, Kalnins A, Kalyanasundaram A, Kandzari DE, Kao HL, Karmpaliotis D, Kassem HH, Khatri J, Knaapen P, Kornowski R, Krestyaninov O, Kumar AVG, Lamelas PM, Lee SW, Lefevre T, Leung R, Li Y, Li Y, Lim ST, Lo S, Lombardi W, Maran A, McEntegart M, Moses J, Munawar M, Navarro A, Ngo HM, Nicholson W, Oksnes A, Olivecrona GK, Padilla L, Patel M, Pershad A, Postu M, Qian J, Quadros A, Rafeh NA, Råmunddal T, Prakasa Rao VS, Reifart N, Riley RF, Rinfret S, Saghatelyan M, Sianos G, Smith E, Spaedy A, Spratt J, Stone G, Strange JW, Tammam KO, Thompson CA, Toma A, Tremmel JA, Trinidad RS, Ungi I, Vo M, Vu VH, Walsh S, Werner G, Wojcik J, Wollmuth J, Xu B, Yamane M, Ybarra LF, Yeh RW, Zhang Q. Global Chronic Total Occlusion Crossing Algorithm: JACC State-of-the-Art Review. J Am Coll Cardiol. 2021 Aug 24;78(8):840-853. doi: 10.1016/j.jacc.2021.05.055. PMID: 34412818.
Copy Download .nbib Format: NLM
No impact of mineralocorticoid receptor antagonists on long-term recurrences of ventricular tachyarrhythmias.

Pacing and clinical electrophysiology : PACE

Schupp T, Akin I, Reiser L, Bollow A, Taton G, Borggrefe M, Reichelt T, Ellguth D, Engelke N, Barre M, Müller J, Weidner K, Kim SH, Akin M, Große Meininghaus D, Behnes M.
PMID: 33314234
Pacing Clin Electrophysiol. 2021 Feb;44(2):213-224. doi: 10.1111/pace.14137. Epub 2021 Jan 05.

OBJECTIVE: The study sought to assess the prognostic impact of treatment with mineralocorticoid receptor antagonists (MRA) on recurrences of ventricular tachyarrhythmias in implantable cardioverter-defibrillator (ICD) recipients with systolic heart failure (HF).BACKGROUND: Data regarding the outcome of patients with ventricular...

Cite
Schupp T, Akin I, Reiser L, et al. No impact of mineralocorticoid receptor antagonists on long-term recurrences of ventricular tachyarrhythmias. Pacing Clin Electrophysiol. 2021;44(2):213-224doi: 10.1111/pace.14137.
Schupp, T., Akin, I., Reiser, L., Bollow, A., Taton, G., Borggrefe, M., Reichelt, T., Ellguth, D., Engelke, N., Barre, M., Müller, J., Weidner, K., Kim, S. H., Akin, M., Große Meininghaus, D., & Behnes, M. (2021). No impact of mineralocorticoid receptor antagonists on long-term recurrences of ventricular tachyarrhythmias. Pacing and clinical electrophysiology : PACE, 44(2), 213-224. https://doi.org/10.1111/pace.14137
Schupp, Tobias, et al. "No impact of mineralocorticoid receptor antagonists on long-term recurrences of ventricular tachyarrhythmias." Pacing and clinical electrophysiology : PACE vol. 44,2 (2021): 213-224. doi: https://doi.org/10.1111/pace.14137
Schupp T, Akin I, Reiser L, Bollow A, Taton G, Borggrefe M, Reichelt T, Ellguth D, Engelke N, Barre M, Müller J, Weidner K, Kim SH, Akin M, Große Meininghaus D, Behnes M. No impact of mineralocorticoid receptor antagonists on long-term recurrences of ventricular tachyarrhythmias. Pacing Clin Electrophysiol. 2021 Feb;44(2):213-224. doi: 10.1111/pace.14137. Epub 2021 Jan 05. PMID: 33314234.
Copy Download .nbib Format: NLM
First Generation Osseointegrated Steady State Implant Benefits in Children with Hearing Loss.

Otology & neurotology : official publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology

Gordon KA, Papsin BC, Feness M, Negandhi J, Cushing SL.
PMID: 34935762
Otol Neurotol. 2021 Dec 21; doi: 10.1097/MAO.0000000000003447. Epub 2021 Dec 21.

OBJECTIVE: To assess outcomes of a new Osseointegrated Steady State Implant (OSSI) for bone conduction in adolescents.METHOD: In an initial trial, 14 adolescents (14.5 years of age, SD = 2.22) were provided with an OSSI; unilateral OSSI (n =...

Cite
Gordon KA, Papsin BC, Feness M, et al. First Generation Osseointegrated Steady State Implant Benefits in Children with Hearing Loss. Otol Neurotol. 2021;doi: 10.1097/MAO.0000000000003447.
Gordon, K. A., Papsin, B. C., Feness, M., Negandhi, J., & Cushing, S. L. (2021). First Generation Osseointegrated Steady State Implant Benefits in Children with Hearing Loss. Otology & neurotology : official publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology, . https://doi.org/10.1097/MAO.0000000000003447
Gordon, Karen A, et al. "First Generation Osseointegrated Steady State Implant Benefits in Children with Hearing Loss." Otology & neurotology : official publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology vol. (2021). doi: https://doi.org/10.1097/MAO.0000000000003447
Gordon KA, Papsin BC, Feness M, Negandhi J, Cushing SL. First Generation Osseointegrated Steady State Implant Benefits in Children with Hearing Loss. Otol Neurotol. 2021 Dec 21; doi: 10.1097/MAO.0000000000003447. Epub 2021 Dec 21. PMID: 34935762.
Copy Download .nbib Format: NLM
Industrial Processing of Algerian Table Olive Cultivars Elaborated as Spanish Style.

Frontiers in microbiology

Sab C, Romero C, Brenes M, Montaño A, Ouelhadj A, Medina E.
PMID: 34803946
Front Microbiol. 2021 Nov 04;12:729436. doi: 10.3389/fmicb.2021.729436. eCollection 2021.

Olives from the Sigoise, Verdale, and Sevillana cultivars were elaborated as Spanish-style table olives by four Algerian factories, and the quality and food safety of the industrial table olives have been studied by the analysis of physicochemical and microbiological...

Cite
Sab C, Romero C, Brenes M, et al. Industrial Processing of Algerian Table Olive Cultivars Elaborated as Spanish Style. Front Microbiol. 2021;12:729436doi: 10.3389/fmicb.2021.729436.
Sab, C., Romero, C., Brenes, M., Montaño, A., Ouelhadj, A., & Medina, E. (2021). Industrial Processing of Algerian Table Olive Cultivars Elaborated as Spanish Style. Frontiers in microbiology, 12729436. https://doi.org/10.3389/fmicb.2021.729436
Sab, Chafiaa, et al. "Industrial Processing of Algerian Table Olive Cultivars Elaborated as Spanish Style." Frontiers in microbiology vol. 12 (2021): 729436. doi: https://doi.org/10.3389/fmicb.2021.729436
Sab C, Romero C, Brenes M, Montaño A, Ouelhadj A, Medina E. Industrial Processing of Algerian Table Olive Cultivars Elaborated as Spanish Style. Front Microbiol. 2021 Nov 04;12:729436. doi: 10.3389/fmicb.2021.729436. eCollection 2021. PMID: 34803946; PMCID: PMC8600317.
Copy Download .nbib Format: NLM
Neurofibromatosis type 2 predisposes to ependymomas of various localization, histology, and molecular subtype.

Acta neuropathologica

Kresbach C, Dorostkar MM, Suwala AK, Wefers AK, Schweizer L, Engertsberger L, Bison B, Mynarek M, Kloth-Stachnau K, Spohn M, von Deimling A, Benesch M, Hagel C, Mautner VF, Rutkowski S, Schüller U.
PMID: 33844070
Acta Neuropathol. 2021 Jun;141(6):971-974. doi: 10.1007/s00401-021-02304-4. Epub 2021 Apr 12.

No abstract available.

Cite
Kresbach C, Dorostkar MM, Suwala AK, et al. Neurofibromatosis type 2 predisposes to ependymomas of various localization, histology, and molecular subtype. Acta Neuropathol. 2021;141(6):971-974doi: 10.1007/s00401-021-02304-4.
Kresbach, C., Dorostkar, M. M., Suwala, A. K., Wefers, A. K., Schweizer, L., Engertsberger, L., Bison, B., Mynarek, M., Kloth-Stachnau, K., Spohn, M., von Deimling, A., Benesch, M., Hagel, C., Mautner, V. F., Rutkowski, S., & Schüller, U. (2021). Neurofibromatosis type 2 predisposes to ependymomas of various localization, histology, and molecular subtype. Acta neuropathologica, 141(6), 971-974. https://doi.org/10.1007/s00401-021-02304-4
Kresbach, Catena, et al. "Neurofibromatosis type 2 predisposes to ependymomas of various localization, histology, and molecular subtype." Acta neuropathologica vol. 141,6 (2021): 971-974. doi: https://doi.org/10.1007/s00401-021-02304-4
Kresbach C, Dorostkar MM, Suwala AK, Wefers AK, Schweizer L, Engertsberger L, Bison B, Mynarek M, Kloth-Stachnau K, Spohn M, von Deimling A, Benesch M, Hagel C, Mautner VF, Rutkowski S, Schüller U. Neurofibromatosis type 2 predisposes to ependymomas of various localization, histology, and molecular subtype. Acta Neuropathol. 2021 Jun;141(6):971-974. doi: 10.1007/s00401-021-02304-4. Epub 2021 Apr 12. PMID: 33844070; PMCID: PMC8113165.
Copy Download .nbib Format: NLM
A Profound Basic Characterization of eIFs in Gliomas: Identifying eIF3I and 4H as Potential Novel Target Candidates in Glioma Therapy.

Cancers

Krassnig S, Wohlrab C, Golob-Schwarzl N, Raicht A, Schatz C, Birkl-Toeglhofer AM, Skofler C, Gantenbein N, Leoni M, Asslaber M, Leber SL, Mahdy-Ali K, von Campe G, Mayer M, Borenich A, Weis S, Benesch M, Haybaeck J.
PMID: 33807050
Cancers (Basel). 2021 Mar 23;13(6). doi: 10.3390/cancers13061482.

Glioblastoma (GBM) is an utterly devastating cerebral neoplasm and current therapies only marginally improve patients' overall survival (OS). The PI3K/AKT/mTOR pathway participates in gliomagenesis through regulation of cell growth and proliferation. Since it is an upstream regulator of the...

Cite
Krassnig S, Wohlrab C, Golob-Schwarzl N, et al. A Profound Basic Characterization of eIFs in Gliomas: Identifying eIF3I and 4H as Potential Novel Target Candidates in Glioma Therapy. Cancers (Basel). 2021;13(6)doi: 10.3390/cancers13061482.
Krassnig, S., Wohlrab, C., Golob-Schwarzl, N., Raicht, A., Schatz, C., Birkl-Toeglhofer, A. M., Skofler, C., Gantenbein, N., Leoni, M., Asslaber, M., Leber, S. L., Mahdy-Ali, K., von Campe, G., Mayer, M., Borenich, A., Weis, S., Benesch, M., & Haybaeck, J. (2021). A Profound Basic Characterization of eIFs in Gliomas: Identifying eIF3I and 4H as Potential Novel Target Candidates in Glioma Therapy. Cancers, 13(6), . https://doi.org/10.3390/cancers13061482
Krassnig, Stefanie, et al. "A Profound Basic Characterization of eIFs in Gliomas: Identifying eIF3I and 4H as Potential Novel Target Candidates in Glioma Therapy." Cancers vol. 13,6 (2021). doi: https://doi.org/10.3390/cancers13061482
Krassnig S, Wohlrab C, Golob-Schwarzl N, Raicht A, Schatz C, Birkl-Toeglhofer AM, Skofler C, Gantenbein N, Leoni M, Asslaber M, Leber SL, Mahdy-Ali K, von Campe G, Mayer M, Borenich A, Weis S, Benesch M, Haybaeck J. A Profound Basic Characterization of eIFs in Gliomas: Identifying eIF3I and 4H as Potential Novel Target Candidates in Glioma Therapy. Cancers (Basel). 2021 Mar 23;13(6). doi: 10.3390/cancers13061482. PMID: 33807050; PMCID: PMC8004965.
Copy Download .nbib Format: NLM
Types of deviation and review criteria in pretreatment central quality control of tumor bed boost in medulloblastoma-an analysis of the German Radiotherapy Quality Control Panel in the SIOP PNET5 MB trial.

Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al]

Dietzsch S, Braesigk A, Seidel C, Remmele J, Kitzing R, Schlender T, Mynarek M, Geismar D, Jablonska K, Schwarz R, Pazos M, Weber DC, Frick S, Gurtner K, Matuschek C, Harrabi SB, Glück A, Lewitzki V, Dieckmann K, Benesch M, Gerber NU, Obrecht D, Rutkowski S, Timmermann B, Kortmann RD.
PMID: 34351451
Strahlenther Onkol. 2021 Aug 05; doi: 10.1007/s00066-021-01822-0. Epub 2021 Aug 05.

PURPOSE: In Germany, Austria, and Switzerland, pretreatment radiotherapy quality control (RT-QC) for tumor bed boost (TB) in non-metastatic medulloblastoma (MB) was not mandatory but was recommended for patients enrolled in the SIOP PNET5 MB trial between 2014 and 2018....

Cite
Dietzsch S, Braesigk A, Seidel C, et al. Types of deviation and review criteria in pretreatment central quality control of tumor bed boost in medulloblastoma-an analysis of the German Radiotherapy Quality Control Panel in the SIOP PNET5 MB trial. Strahlenther Onkol. 2021;doi: 10.1007/s00066-021-01822-0.
Dietzsch, S., Braesigk, A., Seidel, C., Remmele, J., Kitzing, R., Schlender, T., Mynarek, M., Geismar, D., Jablonska, K., Schwarz, R., Pazos, M., Weber, D. C., Frick, S., Gurtner, K., Matuschek, C., Harrabi, S. B., Glück, A., Lewitzki, V., Dieckmann, K., Benesch, M., Gerber, N. U., Obrecht, D., Rutkowski, S., Timmermann, B., & Kortmann, R. D. (2021). Types of deviation and review criteria in pretreatment central quality control of tumor bed boost in medulloblastoma-an analysis of the German Radiotherapy Quality Control Panel in the SIOP PNET5 MB trial. Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al], . https://doi.org/10.1007/s00066-021-01822-0
Dietzsch, Stefan, et al. "Types of deviation and review criteria in pretreatment central quality control of tumor bed boost in medulloblastoma-an analysis of the German Radiotherapy Quality Control Panel in the SIOP PNET5 MB trial." Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al] vol. (2021). doi: https://doi.org/10.1007/s00066-021-01822-0
Dietzsch S, Braesigk A, Seidel C, Remmele J, Kitzing R, Schlender T, Mynarek M, Geismar D, Jablonska K, Schwarz R, Pazos M, Weber DC, Frick S, Gurtner K, Matuschek C, Harrabi SB, Glück A, Lewitzki V, Dieckmann K, Benesch M, Gerber NU, Obrecht D, Rutkowski S, Timmermann B, Kortmann RD. Types of deviation and review criteria in pretreatment central quality control of tumor bed boost in medulloblastoma-an analysis of the German Radiotherapy Quality Control Panel in the SIOP PNET5 MB trial. Strahlenther Onkol. 2021 Aug 05; doi: 10.1007/s00066-021-01822-0. Epub 2021 Aug 05. PMID: 34351451.
Copy Download .nbib Format: NLM
Showing 169 to 177 of 177 entries